Oncimmune FY revenues tracking in line with expectations
8th Jun 2021 10:57
(Sharecast News) - Immunodiagnostics group Oncimmune said on Tuesday that 2021 full-year revenues were in line with market expectations,
Read moreOncimmune secures contracts with Roche and Cedars-Sinai
6th Apr 2021 09:14
(Sharecast News) - Immunodiagnostics group Oncimmune said on Tuesday that it had signed two separate agreements for the use of its newly developed and proprietary Infectious Disease panel with Roche Pharmaceuticals and Cedars-Sinai Medical Center.
Read moreOncimmune signs two NHS contracts, has NICE guidance published
14th Dec 2020 14:54
(Sharecast News) - Oncimmune has signed a commercial contract to supply its 'EarlyCDT Lung' blood test to NHS Norfolk & Waveney Clinical Commissioning Group, it announced on Monday.
Read moreOncimmune enters deal with Augmenta to profile plasma samples
11th Nov 2020 10:13
(Sharecast News) - Immunodiagnostics group Oncimmune has signed a new master service agreement with Augmenta Bioworks, it announced on Wednesday, to profile patient plasma samples and characterise therapeutic candidates discovered through Augmenta's 'SingleCyte' and 'DeepGrid' discovery platforms.
Read moreOncimmune granted funding for Covid-19 research collaboration
6th Oct 2020 13:54
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced the award of funding from UK Research and Innovation's (UKRI) 'Ideas to Address Covid-19' programme on Tuesday.
Read moreOncimmune enters collaboration with Roche subsidiary
23rd Sep 2020 16:05
(Sharecast News) - Immunodiagnostics group Oncimmune Holdings has signed a collaboration with Roche subsidiary Genentech, it announced on Wednesday, to characterise the autoantibody profiles of patients in clinical trials for rheumatological diseases, including systemic lupus erythematosus (SLE).
Read moreOncimmune announces autoantibody profiling collaboration
2nd Sep 2020 13:49
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has signed an autoantibody profiling collaboration with an unnamed "leading global biopharmaceutical company", it announced on Wednesday, which it said had "extensive experience" in developing novel immune checkpoint inhibitors (CPIs).
Read moreRoche extends scope and value of contract with Oncimmune
27th Jul 2020 09:22
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Monday that Roche has exercised its option to increase the scope and value of the cornerstone contract, initially announced on 28 May.
Read moreOncimmune expects to report further strong top-line growth
4th Jun 2020 10:50
(Sharecast News) - Immunodiagnostics group Oncimmune Holdings said on Thursday that it expects to report further strong top-line growth in its current trading year.
Read moreOncimmune signs collaboration deal with US biopharma company
12th May 2020 15:32
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has signed an antigen-targeting collaboration, it announced on Tuesday, to support drug development with a "leading", unnamed United States biopharmaceutical company, which is developing novel therapies based on the human immune response.
Read moreOncimmune funded into 2021 with new EUR 8.5m facility
20th Sep 2019 15:47
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has secured a credit facility of €8.5m (£7.5m) with IPF Management, it announced on Friday.
Read moreOncimmune sells US operations to and partners with Biodesix
28th Jun 2019 11:03
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has entered into an exclusive partnership agreement, it announced on Friday, which it said could "unlock the full potential" of its 'EarlyCDT Lung' product in the United States.
Read moreOncimmune confident of 'material profitable revenues'
26th Jun 2019 10:58
(Sharecast News) - Immunodiagnostics firm Oncimmune told investors on Wednesday it was confident it could generate "material profitable revenues" on the back of several business developments.
Read moreOncimmune distributor gets approval for 'EarlyCDT-Lung' in Israel
15th May 2019 15:27
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Wednesday that its distributor for Israel, Best Medical Opinion, has received regulatory approval for the sale of the 'EarlyCDT-Lung' product in Israel.
Read moreOncimmune begins study to bring 'EarlyCDT-Lung' to China
10th May 2019 12:59
(Sharecast News) - Oncimmune Holdings, alongside its partner Genostics Company, announced the start of a multi-centre case control study on early lung cancer detection for screening and nodules in the People's Republic of China on Friday, using an extended panel of autoantibodies to accommodate variations in the biomarkers expressed on cancer cells in Asian populations.
Read more